434 related articles for article (PubMed ID: 23480362)
1. Multiple antigen peptide containing B and T cell epitopes of F1 antigen of Yersinia pestis showed enhanced Th1 immune response in murine model.
Ali R; Naqvi RA; Kumar S; Bhat AA; Rao DN
Scand J Immunol; 2013 May; 77(5):361-71. PubMed ID: 23480362
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of CD4+/CD8+ T-cell expression and IFN-γ, perforin secretion for B-T constructs of F1 and V antigens of Yersinia pestis.
Gupta G; Ali R; Khan AA; Rao DN
Int Immunopharmacol; 2012 Jan; 12(1):64-73. PubMed ID: 22094541
[TBL] [Abstract][Full Text] [Related]
3. Cell-mediated immune response to epitopic MAP (multiple antigen peptide) construct of LcrV antigen of Yersinia pestis in murine model.
Shreewastav RK; Ali R; Uppada JB; Rao DN
Cell Immunol; 2012; 278(1-2):55-62. PubMed ID: 23121976
[TBL] [Abstract][Full Text] [Related]
4. Enhanced humoral and mucosal immune responses after intranasal immunization with chimeric multiple antigen peptide of LcrV antigen epitopes of Yersinia pestis coupled to palmitate in mice.
Uppada SB; Bhat AA; Sah A; Donthamshetty RN
Vaccine; 2011 Nov; 29(50):9352-60. PubMed ID: 22001881
[TBL] [Abstract][Full Text] [Related]
5. Multiple antigen peptide consisting of B- and T-cell epitopes of F1 antigen of Y. pestis showed enhanced humoral and mucosal immune response in different strains of mice.
Ali R; Kumar S; Naqvi RA; Sheikh IA; Rao DN
Int Immunopharmacol; 2013 Jan; 15(1):97-105. PubMed ID: 23174507
[TBL] [Abstract][Full Text] [Related]
6. Cell-mediated immune response and Th/Th cytokine profile of B-T constructs of F1 and V antigen of Yersinia pestis.
Gupta G; Khan AA; Rao DN
Scand J Immunol; 2010 Mar; 71(3):186-98. PubMed ID: 20415784
[TBL] [Abstract][Full Text] [Related]
7. Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles.
Sabhnani L; Manocha M; Sridevi K; Shashikiran D; Rayanade R; Rao DN
FEMS Immunol Med Microbiol; 2003 Oct; 38(3):215-29. PubMed ID: 14522457
[TBL] [Abstract][Full Text] [Related]
8. B and T cell epitope mapping and study the humoral and cell mediated immune response to B-T constructs of YscF antigen of Yersinia pestis.
Ali R; Kumar S; Naqvi RA; Rao DN
Comp Immunol Microbiol Infect Dis; 2013 Jul; 36(4):365-78. PubMed ID: 23465748
[TBL] [Abstract][Full Text] [Related]
9. Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis.
Khan AA; Babu JP; Gupta G; Rao DN
Vaccine; 2008 Jan; 26(3):316-32. PubMed ID: 18096277
[TBL] [Abstract][Full Text] [Related]
10. Inducing systemic and mucosal immune responses to B-T construct of F1 antigen of Yersinia pestis in microsphere delivery.
Tripathi V; Chitralekha KT; Bakshi AR; Tomar D; Deshmukh RA; Baig MA; Rao DN
Vaccine; 2006 Apr; 24(16):3279-89. PubMed ID: 16476510
[TBL] [Abstract][Full Text] [Related]
11. A Recombinant Attenuated
Singh AK; Curtiss R; Sun W
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31331960
[TBL] [Abstract][Full Text] [Related]
12. CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague.
Amemiya K; Meyers JL; Rogers TE; Fast RL; Bassett AD; Worsham PL; Powell BS; Norris SL; Krieg AM; Adamovicz JJ
Vaccine; 2009 Apr; 27(16):2220-9. PubMed ID: 19428836
[TBL] [Abstract][Full Text] [Related]
13. Novel CTL epitopes identified through a Y. pestis proteome-wide analysis in the search for vaccine candidates against plague.
Zvi A; Rotem S; Zauberman A; Elia U; Aftalion M; Bar-Haim E; Mamroud E; Cohen O
Vaccine; 2017 Oct; 35(44):5995-6006. PubMed ID: 28606812
[TBL] [Abstract][Full Text] [Related]
14. Yersinia pestis V protein epitopes recognized by CD4 T cells.
Parent MA; Berggren KN; Mullarky IK; Szaba FM; Kummer LW; Adamovicz JJ; Smiley ST
Infect Immun; 2005 Apr; 73(4):2197-204. PubMed ID: 15784563
[TBL] [Abstract][Full Text] [Related]
15. Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.
Derbise A; Hanada Y; Khalifé M; Carniel E; Demeure CE
PLoS Negl Trop Dis; 2015; 9(10):e0004162. PubMed ID: 26473734
[TBL] [Abstract][Full Text] [Related]
16. Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection.
Philipovskiy AV; Smiley ST
Infect Immun; 2007 Feb; 75(2):878-85. PubMed ID: 17118978
[TBL] [Abstract][Full Text] [Related]
17. Protective CD4 T cells targeting cryptic epitopes of Mycobacterium tuberculosis resist infection-driven terminal differentiation.
Woodworth JS; Aagaard CS; Hansen PR; Cassidy JP; Agger EM; Andersen P
J Immunol; 2014 Apr; 192(7):3247-58. PubMed ID: 24574499
[TBL] [Abstract][Full Text] [Related]
18. Humoral and cellular immune response of mice challenged with Yersinia pestis antigenic preparations.
Leal EA; Moreira JD; Nunes FF; Souza LR; Martins JM; Toledo VPC; Almeida AMP; Guimarães TMP
Braz J Infect Dis; 2017; 21(6):620-626. PubMed ID: 29031042
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.
Cassataro J; Estein SM; Pasquevich KA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH
Infect Immun; 2005 Dec; 73(12):8079-88. PubMed ID: 16299302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
